| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NexImmune, Inc. | Chief Medical Officer | Stock Options (Right to Buy) | 48,000 | 05 Apr 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122023747-knight-robert-douglas-2022-04-05 | NexImmune, Inc. | 05 Apr 2022 | 1 | $0 | 4 | Chief Medical Officer | 07 Apr 2022, 19:13 |